Cargando…

Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment

Tumor hypoxia is a severe problem affecting tumor therapy because it reduces the sensitivity of chemotherapy and radiation therapy. Ozone has been known to improve peripheral blood perfusion and oxygen partial pressure. The effect of ozonated water on tumor hypoxia, alone and in combination with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroda, Kohei, Yamashita, Masamiti, Murahata, Yusuke, Azuma, Kazuo, Osaki, Tomohiro, Tsuka, Takeshi, Ito, Norihiko, Imagawa, Tomohiro, Okamoto, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122405/
https://www.ncbi.nlm.nih.gov/pubmed/30186377
http://dx.doi.org/10.3892/etm.2018.6415
_version_ 1783352650448764928
author Kuroda, Kohei
Yamashita, Masamiti
Murahata, Yusuke
Azuma, Kazuo
Osaki, Tomohiro
Tsuka, Takeshi
Ito, Norihiko
Imagawa, Tomohiro
Okamoto, Yoshiharu
author_facet Kuroda, Kohei
Yamashita, Masamiti
Murahata, Yusuke
Azuma, Kazuo
Osaki, Tomohiro
Tsuka, Takeshi
Ito, Norihiko
Imagawa, Tomohiro
Okamoto, Yoshiharu
author_sort Kuroda, Kohei
collection PubMed
description Tumor hypoxia is a severe problem affecting tumor therapy because it reduces the sensitivity of chemotherapy and radiation therapy. Ozone has been known to improve peripheral blood perfusion and oxygen partial pressure. The effect of ozonated water on tumor hypoxia, alone and in combination with an antitumor drug was studied in the present study. Following intraperitoneal administration of ozonated water to colon-26-bearing mice, the Hoechst 33342-positive area and the intratumoral oxygen partial pressure was significantly increased. The tumor growth rate was more suppressed when ozonated water was combined with cisplatin (CDDP) compared with CDDP treatment alone. The number of Ki-67-positive cells significantly decreased, whereas the number of TUNEL-positive cells significantly increased. The present study showed that ozonated water increased intratumoral blood perfusion and improved tumor hypoxia. In addition, ozonated water increased the therapeutic effect of CDDP. These findings, as well as previous reports, suggest that tumor growth is suppressed after treatment with ozonated water as the amount of CDDP reaching the tumor is increased when the intratumoral blood perfusion is increased due to the ozonated water. Thus, the administration of ozonated water may be a new therapeutic approach to solve current concerns regarding antitumor treatment.
format Online
Article
Text
id pubmed-6122405
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-61224052018-09-05 Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment Kuroda, Kohei Yamashita, Masamiti Murahata, Yusuke Azuma, Kazuo Osaki, Tomohiro Tsuka, Takeshi Ito, Norihiko Imagawa, Tomohiro Okamoto, Yoshiharu Exp Ther Med Articles Tumor hypoxia is a severe problem affecting tumor therapy because it reduces the sensitivity of chemotherapy and radiation therapy. Ozone has been known to improve peripheral blood perfusion and oxygen partial pressure. The effect of ozonated water on tumor hypoxia, alone and in combination with an antitumor drug was studied in the present study. Following intraperitoneal administration of ozonated water to colon-26-bearing mice, the Hoechst 33342-positive area and the intratumoral oxygen partial pressure was significantly increased. The tumor growth rate was more suppressed when ozonated water was combined with cisplatin (CDDP) compared with CDDP treatment alone. The number of Ki-67-positive cells significantly decreased, whereas the number of TUNEL-positive cells significantly increased. The present study showed that ozonated water increased intratumoral blood perfusion and improved tumor hypoxia. In addition, ozonated water increased the therapeutic effect of CDDP. These findings, as well as previous reports, suggest that tumor growth is suppressed after treatment with ozonated water as the amount of CDDP reaching the tumor is increased when the intratumoral blood perfusion is increased due to the ozonated water. Thus, the administration of ozonated water may be a new therapeutic approach to solve current concerns regarding antitumor treatment. D.A. Spandidos 2018-09 2018-07-06 /pmc/articles/PMC6122405/ /pubmed/30186377 http://dx.doi.org/10.3892/etm.2018.6415 Text en Copyright: © Kuroda et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Kuroda, Kohei
Yamashita, Masamiti
Murahata, Yusuke
Azuma, Kazuo
Osaki, Tomohiro
Tsuka, Takeshi
Ito, Norihiko
Imagawa, Tomohiro
Okamoto, Yoshiharu
Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
title Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
title_full Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
title_fullStr Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
title_full_unstemmed Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
title_short Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
title_sort use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122405/
https://www.ncbi.nlm.nih.gov/pubmed/30186377
http://dx.doi.org/10.3892/etm.2018.6415
work_keys_str_mv AT kurodakohei useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT yamashitamasamiti useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT murahatayusuke useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT azumakazuo useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT osakitomohiro useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT tsukatakeshi useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT itonorihiko useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT imagawatomohiro useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment
AT okamotoyoshiharu useofozonatedwaterasanewtherapeuticapproachtosolvecurrentconcernsaroundantitumortreatment